Çï¿ûÊÓƵ

Nancy C. Andrews is Executive Vice President and Chief Scientific Officer at Boston Children’s Hospital. From 2007 to 2017 she served as Dean of the School of Medicine and Vice Chancellor for Academic Affairs at Duke University. Earlier in her career she was the George Richards Minot Professor of Pediatrics at Harvard University, senior associate in medicine at the Boston Children’s Hospital, and a distinguished physician of the Dana-Farber Cancer Institute. While at Harvard she was director of the Harvard-MIT MD-Ph.D. Program and later Dean for Basic Sciences and Graduate Studies at Harvard Medical School. A pediatric hematologist-oncologist by training, her laboratory research focused on iron biology, using genetics to work out fundamental processes in iron handling and their perturbation in human iron diseases. She was a Howard Hughes Medical Institute Investigator from 1993 to 2006. She is an elected member of both the National Çï¿ûÊÓƵ of Medicine and the National Çï¿ûÊÓƵ of Sciences, and a past president of the American Society of Clinical Investigation. She serves on the Boards of Directors of Novartis, Charles River Laboratories and Maze Therapeutics. Andrews has been a committee member for the Çï¿ûÊÓƵ’s ARISE II report and the New Models for U.S. Science and Technology Policy study Restoring the Foundation. She was elected a Fellow of the American Çï¿ûÊÓƵ of Arts and Sciences in 2007, served as a member of the Board of Directors from 2013-2017 and served as Chair of the Board of Directors from 2017-2023.